What does rectum cancer symptom have augural

summary

Advanced rectal cancer patients are more difficult, not only more and more uncomfortable in the body, but also more and more frequent and urgent. In addition, the tumor I in the body of the patient will continue to increase. In this way, the intestinal cavity of the patient will become more and more narrow, and even the symptoms of intestinal obstruction will appear. Once diagnosed as intestinal obstruction is relatively difficult to treat, and patients are even more prone to abdominal pain, abdominal distension symptoms, and even constipation. At this time, we need to pay attention to diet. Let me share with you what are the signs of rectal cancer symptoms.

What does rectum cancer symptom have augural

Symptom 1: rectal cancer growth to a certain extent can appear bloody stool symptoms. A small amount of bleeding is not easy to find with the naked eye, but a large number of red blood cells can be found when using the microscope to check the feces. The so-called fecal occult blood test is positive. When the amount of bleeding is large, there can be bloody stool, and the blood color is bright red or dark red. When the surface of cancer ulcers, the formation of ulcers, tumor necrosis infection, can appear pus blood, mucus bloody stool, this is the symptom of rectal cancer.

Symptom 2: patients can have varying degrees of feeling, anal drop feeling, sometimes diarrhea, which is also a common symptom of rectal cancer.

Symptom 3: when rectal tumor causes intestinal stenosis, intestinal obstruction symptoms (abdominal pain, abdominal distension, difficult defecation) of different degrees may appear, abdominal pain and bowel sounds before defecation, and symptoms are relieved after defecation. Defecation variable thin, with groove, is one of the symptoms of rectal cancer.

matters needing attention

In the selection of multiple targeted drugs for treatment, it should be noted that the target of the two targeted drugs is different, because the current clinical research data show that when the targeted drugs are added to the treatment, the efficacy does not increase, and the survival time of patients after drug treatment does not extend.